Infection and Sepsis Trends during United States' Delivery Hospitalizations from 2000 to 2020

Abstract

Objective This study aimed to evaluate trends, risk factors, and outcomes associated with infections and sepsis during delivery hospitalizations in the United States.

Study Design The 2000–2020 National Inpatient Sample was used for this repeated cross-sectional analysis. Delivery hospitalizations of patients aged 15 to 54 with and without infection and sepsis were identified. Common infection diagnoses during delivery hospitalizations analyzed included (i) pyelonephritis, (ii) pneumonia/influenza, (iii) endometritis, (iv) cholecystitis, (v) chorioamnionitis, and (vi) wound infection. Temporal trends in sepsis and infection during delivery hospitalizations were analyzed. The associations between sepsis and infection and common chronic health conditions including asthma, chronic hypertension, pregestational diabetes, and obesity were analyzed. The associations between clinical, demographic, and hospital characteristics, and infection and sepsis were determined with unadjusted and adjusted logistic regression models with unadjusted odds ratio (OR) and adjusted odds ratios with 95% confidence intervals as measures of association.

Results An estimated 80,158,622 delivery hospitalizations were identified and included in the analysis, of which 2,766,947 (3.5%) had an infection diagnosis and 32,614 had a sepsis diagnosis (4.1 per 10,000). The most common infection diagnosis was chorioamnionitis (2.7% of deliveries) followed by endometritis (0.4%), and wound infections (0.3%). Infection and sepsis were more common in the setting of chronic health conditions. Evaluating trends in individual infection diagnoses, endometritis and wound infection decreased over the study period both for patients with and without chronic conditions, while risk for pyelonephritis and pneumonia/influenza increased. Sepsis increased over the study period for deliveries with and without chronic condition diagnoses. Risks for adverse outcomes including mortality, severe maternal morbidity, the critical care composite, and acute renal failure were all significantly increased in the presence of sepsis and infection.

Conclusion Endometritis and wound infections decreased over the study period while risk for sepsis increased. Infection and sepsis were associated with chronic health conditions and accounted for a significant proportion of adverse obstetric outcomes including severe maternal morbidity.

Key Points

• Sepsis increased over the study period for deliveries with and without chronic condition diagnoses.

• Endometritis and wound infection decreased over the study period.

• Infection and sepsis accounted for a significant proportion of adverse obstetric outcomes.

Keywords

obstetric sepsis - maternal safety - maternal outcomes - severe maternal morbidity

Publikationsverlauf

Eingereicht: 09. Januar 2024

Angenommen: 28. Januar 2024

Artikel online veröffentlicht:
26. Februar 2024

• References

• 1 The Centers for Disease Control and Prevention. Pregnancy Mortality Surveillance System. Accessed May 1, 2023 at: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm
• 2 Hensley MK, Bauer ME, Admon LK, Prescott HC. Incidence of maternal sepsis and sepsis-related maternal deaths in the United States. JAMA 2019; 322 (09) 890-892
• 3 Bauer ME, Bateman BT, Bauer ST, Shanks AM, Mhyre JM. Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg 2013; 117 (04) 944-950
• 4 Tuuli MG, Liu J, Stout MJ. et al. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med 2016; 374 (07) 647-655
• 5 Lakhi NA, Tricorico G, Osipova Y, Moretti ML. Vaginal cleansing with chlorhexidine gluconate or povidone-iodine prior to cesarean delivery: a randomized comparator-controlled trial. Am J Obstet Gynecol MFM 2019; 1 (01) 2-9
• 6 Valent AM, DeArmond C, Houston JM. et al. Effect of post-cesarean delivery oral cephalexin and metronidazole on surgical site infection among obese women: a randomized clinical trial. JAMA 2017; 318 (11) 1026-1034
• 7 The American College of Obstetricians and Gynecologists. Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection. Obstet Gynecol 2017; 130 (02) e95-e101
• 8 Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2014; 2014 (10) CD007482
• 9 Tita AT, Szychowski JM, Boggess K. et al; C/SOAP Trial Consortium. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med 2016; 375 (13) 1231-1241
• 10 Klebanoff MA, Snowden JM. Historical (retrospective) cohort studies and other epidemiologic study designs in perinatal research. Am J Obstet Gynecol 2018; 219 (05) 447-450
• 11 Healthcare Cost and Utilization Project. Overview of the the National (Nationwide) Inpatient Sample. Accessed May 1, 2023 at: https://www.hcup-us.ahrq.gov/nisoverview.jsp
• 12 Healthcare Cost and Utilization Project. Trend Weights for HCUP NIS Data. Accessed May 1, 2023 at: https://www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp
• 13 The Healthcare Cost and Utilization Project. NIS Description of Data Elements. Accessed May 1, 2023 at: https://www.hcup-us.ahrq.gov/db/vars/dxn/nisnote.jsp
• 14 Centers for Medicare & Medicaid Services. ICD-10. Accessed May 1, 2023 at: https://www.cms.gov/Medicare/Coding/ICD10/
• 15 The Centers for Disease Control and Prevention. Severe Maternal Morbidity in the United States. Accessed May 1, 2023 at: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/severematernalmorbidity.html
• 16 Chantry AA, Deneux-Tharaux C, Bonnet MP, Bouvier-Colle MH. Pregnancy-related ICU admissions in France: trends in rate and severity, 2006-2009. Crit Care Med 2015; 43 (01) 78-86
• 17 Wanderer JP, Leffert LR, Mhyre JM, Kuklina EV, Callaghan WM, Bateman BT. Epidemiology of obstetric-related ICU admissions in Maryland: 1999-2008*. Crit Care Med 2013; 41 (08) 1844-1852
• 18 Sriram S, Robertson MS. Critically ill obstetric patients in Australia: a retrospective audit of 8 years' experience in a tertiary intensive care unit. Crit Care Resusc 2008; 10 (02) 124
• 19 Oud L. Epidemiology of pregnancy-associated ICU utilization in Texas: 2001 - 2010. J Clin Med Res 2017; 9 (02) 143-153
• 20 Zieleskiewicz L, Chantry A, Duclos G. et al. Intensive care and pregnancy: epidemiology and general principles of management of obstetrics ICU patients during pregnancy. Anaesth Crit Care Pain Med 2016; 35 (Suppl. 01) S51-S57
• 21 Kern-Goldberger AR, Arditi B, Wen T. et al. Risk for and disparities in critical care during delivery hospitalizations. Am J Obstet Gynecol MFM 2021; 3 (04) 100354
• 22 Kuklina EV, Whiteman MK, Hillis SD. et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J 2008; 12 (04) 469-477
• 23 Clapp MA, James KE, Friedman AM. Identification of delivery encounters using International Classification of Diseases, Tenth Revision, Diagnosis and Procedure Codes. Obstet Gynecol 2020; 136 (04) 765-767
• 24 Bateman BT, Mhyre JM, Hernandez-Diaz S. et al. Development of a comorbidity index for use in obstetric patients. Obstet Gynecol 2013; 122 (05) 957-965
• 25 National Cancer Institute. Joinpoint Trend Analysis Software. 2020 . Accessed March 20, 2021 at: https://surveillance.cancer.gov/joinpoint/
• 26 Barrio G, Pulido J, Bravo MJ, Lardelli-Claret P, Jiménez-Mejías E, de la Fuente L. An example of the usefulness of joinpoint trend analysis for assessing changes in traffic safety policies. Accid Anal Prev 2015; 75: 292-297
• 27 National Cancer Institute. Average Annual Percent Change (AAPC) and Confidence Interval. Accessed April 1, 2023 at: https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/apc-aapc-tau-confidence-intervals
• 28 Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19 (03) 335-351
• 29 Equator Network. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Accessed March 30, 2023 at: https://www.equator-network.org/reporting-guidelines/strobe/
• 30 Kendle AM, Salemi JL, Tanner JP, Louis JM. Delivery-associated sepsis: trends in prevalence and mortality. Am J Obstet Gynecol 2019; 220 (04) 391.e1-391.e16